May 27, 2023
4 min watch
Save
VIDEO: Verana Health uses IRIS Registry for geographic atrophy research
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- Verana Health is researching geographic atrophy using data from the IRIS Registry.
- A study found that machine learning and ophthalmic images may provide more accurate insights on disease diagnosis and staging.
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Zhongdi Chu, PhD, MSc, discusses Verana Health’s research into geographic atrophy.
“The actual diagnosis and documentation of geographic atrophy has not been extremely accurate in clinical records,” she said. “This is why at Verana Health, we really launched into this research topic of geographic atrophy using both the EHR data we have in the IRIS Registry as well as the ophthalmic images we have in the IRIS Registry powered by machine learning and AI.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Chu reports being employed by Verana Health.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.